Crescent City Surgical Center is categorized under Hospitals in Metairie, LA and active since 2009.
Crescent City Surgical Center was established in 2009, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6214981 by the NAICS.
If you are seeking more information, feel free to contact Karen Guidry, Manager at the company’s single location by writing to 3017 Galleria Drive, Metairie, Louisiana LA 70001 or by phoning (504) 830-2500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Crescent City Surgical Center |
| Contact Person: | Karen Guidry, Manager |
| Address: | 3017 Galleria Drive, Metairie, Louisiana 70001 |
| Phone Number: | (504) 830-2500 |
| Website Address: | ccsurg.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6214981 |
| Share This Business: |
Crescent City Surgical Center was started in 2009 to provide professional Hospitals under the SIC code 8062 and NAICS code 6214981. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Karen Guidry, Manager for inquiries that concern Crescent City Surgical Center by calling the company number (504) 830-2500, as your correspondence is most welcome. Additionally, the physical location of the single location of Crescent City Surgical Center can be found at the coordinates 29.9932,-90.15317 as well as the street address 3017 Galleria Drive in Metairie, Louisiana 70001.
For its online presence, you may visit Crescent City Surgical Center’s website at ccsurg.com and engage with its social media outlets through on Twitter and on Facebook.